Table 3.
Correlations Between JAZF1 Expression and Clinicopathological Parameters (n = 60)
| Characteristics | JAZF1 ID Score | Χ2 | P | |
|---|---|---|---|---|
| 0–4 | 6–12 | |||
| Sex | 0.02 | 1.000 | ||
| Male | 9 | 6 | ||
| Female | 28 | 17 | ||
| Age (years) | 0.40 | 0.749 | ||
| <55 | 28 | 19 | ||
| ≥55 | 9 | 4 | ||
| Tumor size | 0.41 | 0.571 | ||
| ≤1cm | 10 | 8 | ||
| >1cm | 27 | 15 | ||
| TNM stage | 2.68 | 0.262 | ||
| I | 30 | 22 | ||
| II | 6 | 1 | ||
| III | 0 | 0 | ||
| IV | 1 | 0 | ||
| Location | 4.87 | 0.039 | ||
| Unilateral | 27 | 22 | ||
| Bilateral | 10 | 1 | ||
| LNM | 5.96 | 0.024 | ||
| Negative | 8 | 12 | ||
| Positive | 29 | 11 | ||